News Briefing channel feed

Up­start women’s on­col­o­gy com­pa­ny in-li­cens­es PhII PARP; Bei­jing biotech grabs $29M start­up round

8 years ago

No­var­tis backs a $13M round for Anaerophar­ma; Eli Lil­ly in­vest­ing $52M in phar­ma re­search pro­gram with Pur­due

8 years ago

GSK shares hit as an­a­lyst touts po­ten­tial of Mer­ck’s ex­per­i­men­tal HIV drug; In­ter­leukin Ge­net­ics slash­es staff; Tril­li­um looks for part­ners

8 years ago

As­traZeneca and Chi­na part­ner Chi-Med launch a glob­al PhI­II; Zai Lab bags $30M for R&D ef­fort

8 years ago

Gene ther­a­py up­start lands $45M round; Bio­gen picks new com­mu­ni­ca­tions chief

8 years ago

Mi­to­conix lands $20M to de­vel­op neu­rode­gen­er­a­tive plat­form out of Stan­ford; RaNA gets a new name fol­low­ing mR­NA deal with Shire

8 years ago

Langer-in­spired Kala files for an $86M IPO; J&J backs Proven­tion Bio

8 years ago

Mer­ck KGaA gets a thumbs up for once-dead MS drug; Aveo shares soar as ti­vo makes a come­back

8 years ago

Patrick Soon-Sh­iong ac­cused of more con­flicts of in­ter­est; Eli Lil­ly ex­pands in San Diego

8 years ago

Sarep­ta to col­lab­o­rate with Genethon on DMD gene ther­a­py; Chi­nese in­vestors pull back on Pluris­tem in­vest­ment

8 years ago

In wake of a tri­al dis­as­ter, Seat­tle Ge­net­ics files sBLA; Egalet takes a dive on a CRL

8 years ago

No­var­tis chief says Trump visa re­stric­tions sour US hir­ing plans; Parex­el and Sanofi to de­vel­op wear­able de­vices

8 years ago

Loxo rais­ing $227M in post-AS­CO score; Bavar­i­an Nordic re­ports da­ta de­lay; Sonar and Stra­tus or­dered to cease pro­duc­tion

8 years ago

Alexan­dria Launch­Labs opens, J&J an­nounces more col­lab­o­ra­tions

8 years ago

Orum takes $8M in Se­ries A; Twist bags $27M in ven­ture fi­nanc­ing

8 years ago

Ab­b­vie, Prin­cip­ia join forces on im­muno­pro­tea­some in­hibitors; Scripps de­vel­ops hero­in vac­cine, FDA fast tracks NGF pain drug

8 years ago

Seres grabs $20M on PhI­II mi­cro­bio­me launch; Gilead sub­mits NDA; Alk­er­mes be­gins Phase II­Ib study

8 years ago

Bris­tol-My­ers shares drop; Re­gen­era of­fers a life­line to sink­ing Al­co­bra

8 years ago

An­a­lysts project a big spike in COPD mar­ket as new drugs ar­rive; Valeant rais­es $930M in lat­est as­set sale

8 years ago

As­traZeneca rais­es $200M from its lat­est as­set sale; Austin-based Lung Ther­a­peu­tics rais­es $14M in ven­ture cash

8 years ago

WuXi Bi­o­log­ics IPO reaps $509M wind­fall; In­tel­lia strikes CRISPR pact with San Raf­faele

8 years ago

Min­er­va shares jump as J&J hands over $30M, re­vis­es in­som­nia drug pact; Iroko lays off 122

8 years ago

De­ci­phera banks a $52M C round for can­cer R&D; Io­n­is adds $50M mile­stone from Bio­gen

8 years ago

Nicox shares soar on Zervi­ate OK; Gem­phire CEO re­signs; Ar­ray, Ono team up on a $187M deal

8 years ago
First page Previous page 68697071727374 Next page Last page
A service from the Financial Times